Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The effect of sodium cromoglycate alone, and in combination with montelukast sodium, on the airway sensitivity and recovery from challenge with inhaled mannitol in subjects with asthma.

Next Previous
Trial Profile

The effect of sodium cromoglycate alone, and in combination with montelukast sodium, on the airway sensitivity and recovery from challenge with inhaled mannitol in subjects with asthma.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Montelukast (Primary) ; Sodium cromoglicate (Primary)
  • Indications Asthma
  • Focus Therapeutic Use

Most Recent Events

  • 08 May 2009 Additional lead trial centre NHMRC identified as reported by Australian New Zealand Clinical Trials Registry.
  • 19 Jan 2009 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top